The State of Myeloma in 2025
The International Myeloma Foundation talks about the state of myeloma in 2025 through statistical data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program. Significant treatment advancements have also emerged in 2025—newer therapies such as CAR T-cell and bispecific antibodies being used in earlier lines of treatment.
Learn More